🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Adolescents and Young Adults With Cancer

PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study NCT07874828Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Tirzepatide Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer NCT07139769NA1 site📍 Boston Zeba Ahmad, Ph.D. · Tests: Psychosocial Intervention for Parental Caregivers of AYA with Cancer Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites📍 San Francisco📍 Aurora📍 Atlanta Andrew E. Place, MD · Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas NCT04621201n/a10 sites📍 Torino📍 Bologna📍 Bologna Azienda Ospedaliera Ospedale Infantile Regina Margherita Sa… · Tests: observation and biopsy Evaluation of a Psychosocial Support Model for Adolescents and Young Adults Newly Diagnosed With Cancer NCT06979843NA2 sites📍 Gothenburg📍 Stockholm Karolinska Institutet · Tests: A psychosocial model Spanish Validation of a Psychosocial Needs Assessment for Adolescents and Young Adults With Cancer (AYA-POST) NCT07240935NA1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: AYA-POST questionaries A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer NCT07223463NA4 sites📍 Kansas City📍 New York📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Tailored Program, Feedback Program (Uniform Standard of Care) A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy) NCT06561074Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Decitabine, Venetoclax, Calaspargase pegol-mknl E-CANE: a National Program of Remote Health Education Workshops NCT06748820n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Remote Therapeutic Patient Education (e-TPE) Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer NCT06513962Phase 3206 sites📍 Birmingham📍 Birmingham📍 Mobile Children's Oncology Group · Tests: Best Practice, Biospecimen Collection, Electronic Health Record Review, Survey Administration, Triptorelin Pamoate DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations NCT06988475Phase 2, Phase 317 sites📍 Belfast📍 Birmingham📍 Bristol Cancer Research UK · Tests: Capmatinib DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Alectinib Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma NCT07506239NA1 site📍 San Francisco University of California, San Francisco · Tests: Laser Interstitial Thermal Therapy (LITT), Magnetic resonance imaging (MRI), Questionnaires Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors NCT05194397Phase 23 sites📍 Duarte📍 Philadelphia📍 Memphis Children's Hospital of Philadelphia · Tests: Nicotinamide Riboside, Placebo, Exercise Intervention Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors NCT06371768NA1 site📍 Durham Duke University · Tests: AYA Educational Information, AYA STEPS Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy NCT05180825Phase 225 sites📍 Amiens📍 Angers📍 Besançon University Hospital, Strasbourg, France · Tests: Trametinib, Vinblastine Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence NCT05310591Phase 1, Phase 213 sites📍 Bordeaux📍 Lille📍 Lyon Assistance Publique - Hôpitaux de Paris · Tests: Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) ), Nivolumab … Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) NCT06458036Phase 25 sites📍 San Francisco📍 Philadelphia📍 Memphis Children's Hospital of Philadelphia · Tests: Selpercatinib Monotherapy, 131I Therapy Real World Pediatric Oncology Rehabilitation in Italy ( ReWori ) NCT07368582n/a13 sites📍 Bergamo📍 Bologna📍 Bolzano Associazione Italiana Ematologia Oncologia Pediatrica · Tests: Rehabilitation intervention Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer NCT07220343NA1 site📍 Palo Alto Stanford University · Tests: Device, Ecological Momentary Assessment (EMA) via My Personal Health Dashboard (MyPHD) Smartphone App DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. NCT05770544Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Entrectinib Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults NCT06709469Phase 11 site📍 Madrid Instituto de Investigación Hospital Universitario La Paz · Tests: Autologous CD19/CD22 CAR T cells, Allogeneic CART-NKG2D cells A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. NCT06383338Phase 11 site📍 Melbourne Murdoch Childrens Research Institute · Tests: Omeprazole, Dextromethorphan Resilience Mobile App for Teens and Young Adults With Cancer NCT05842902NA1 site📍 Seattle Seattle Children's Hospital · Tests: mPRISM Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention NCT07662239NA3 sites📍 Boston📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Exercise Triage and Personalized Exercise Program SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma NCT04923126Phase 1, Phase 21 site📍 Memphis St. Jude Children's Research Hospital · Tests: Mirdametinib RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL NCT05127148n/a2 sites📍 Paraná📍 CABA Grupo Argentino de Tratamiento de la Leucemia Aguda · Tests: Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category. HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies NCT05658640Phase 1, Phase 236 sites📍 Vienna📍 Ghent📍 Copenhagen Princess Maxima Center for Pediatric Oncology · Tests: Trametinib, Dexamethasone, Cyclophosphamide, Cytarabine, Intrathecal chemotherapy Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma NCT03719105EARLY Phase 16 sites📍 Birmingham📍 Orange📍 San Francisco New York Medical College · Tests: Methotrexate, pralatraxate,, Ifosfamide, Dexamethasone, Etoposide DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. NCT05768178Phase 2, Phase 316 sites📍 Belfast📍 Birmingham📍 Bristol Cancer Research UK · Tests: Vemurafenib, Cobimetinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy